Correction: Cost-Effectiveness of Dupilumab and Oral Janus Kinase Inhibitors for the Treatment of Moderate-to-Severe Atopic Dermatitis in Singapore.
Clarence OngJamaica BrionesZhi Zhen LimNisha Suyien ChandranHaur Yueh LeeBenny Kaihui LiYik Weng YewHwee-Lin WeePublished in: PharmacoEconomics - open (2024)